Work

Abstract PS1-12-28: Real-world outcomes of first line palbociclib combined with endocrine treatment in HR+/HER2- metastatic breast cancer: 5-year data from the French ESME cohort

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-12-28

Authors: T. Grinda, S. Eltaief, E. Brain, T. Bachelot, V. Diéras, F. Dalenc, V. Massard, M. Decrop, A. Coumert, M. Arnedos, A. Mailliez, M. Carton, L. Bosquet, J. Frenel, W. Jacot

Institutions: Institut Gustave Roussy, Fondation Gustave Roussy, UniCancer Group, Institut Curie, Centre Eugène Marquis, Institut universitaire du cancer de Toulouse Oncopole, Institut de Cancérologie de Lorraine, Pfizer (France), Institut Bergonié, Centre Oscar Lambret, Institut de Cancérologie de l'Ouest, Institut Regional du Cancer de Montpellier

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129236379

Cites:

Cited by:

Related to: